Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Italo Poggesi

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Current Opinion in Drug Discovery & Development|February 26, 2004
Predicting human pharmacokinetics from preclinical dataItalo Poggesi
Expert Opinion on Drug Metabolism & Toxicology|October 26, 2010
Current and future directions of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling and simulation: population approach group in Europe 19th annual meetingCharlotte Kloft, Italo Poggesi
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Predictive model for identifying potential CYP2D6 inhibitorsPatrizia Crivori, Italo Poggesi
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 30, 2024
Pharmacokinetics of intranasal drugs, still a missed opportunity?Maria Luisa Sardu, Italo Poggesi
Clinical Pharmacokinetics|July 2, 2017
Prediction of the Effect of Renal Impairment on the Pharmacokinetics of New DrugsElisa Borella, Italo Poggesi, Paolo Magni
Expert Opinion on Drug Discovery|March 19, 2013
Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunityGianluca Nucci, Roberto Gomeni, Italo Poggesi
Expert Opinion on Drug Metabolism & Toxicology|February 13, 2014
The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvementItalo Poggesi, Jan Snoeys, Achiel Van Peer
Molecular Pharmaceutics|May 12, 2006
Computational models for identifying potential P-glycoprotein substrates and inhibitorsPatrizia Crivori, Benedetta Reinach, Daniele Pezzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 29, 2012
Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug developmentApexa Bernard, Holly Kimko, Dinesh Mital, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 27, 2015
Biomarker- versus drug-driven tumor growth inhibition models: an equivalence analysisMaria Luisa Sardu, Italo Poggesi, Giuseppe De Nicolao
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Current Opinion in Drug Discovery & Development|February 26, 2004
Predicting human pharmacokinetics from preclinical dataItalo Poggesi
Expert Opinion on Drug Metabolism & Toxicology|October 26, 2010
Current and future directions of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling and simulation: population approach group in Europe 19th annual meetingCharlotte Kloft, Italo Poggesi
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Predictive model for identifying potential CYP2D6 inhibitorsPatrizia Crivori, Italo Poggesi
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 30, 2024
Pharmacokinetics of intranasal drugs, still a missed opportunity?Maria Luisa Sardu, Italo Poggesi
Clinical Pharmacokinetics|July 2, 2017
Prediction of the Effect of Renal Impairment on the Pharmacokinetics of New DrugsElisa Borella, Italo Poggesi, Paolo Magni
Expert Opinion on Drug Discovery|March 19, 2013
Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunityGianluca Nucci, Roberto Gomeni, Italo Poggesi
Expert Opinion on Drug Metabolism & Toxicology|February 13, 2014
The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvementItalo Poggesi, Jan Snoeys, Achiel Van Peer
Molecular Pharmaceutics|May 12, 2006
Computational models for identifying potential P-glycoprotein substrates and inhibitorsPatrizia Crivori, Benedetta Reinach, Daniele Pezzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 29, 2012
Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug developmentApexa Bernard, Holly Kimko, Dinesh Mital, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 27, 2015
Biomarker- versus drug-driven tumor growth inhibition models: an equivalence analysisMaria Luisa Sardu, Italo Poggesi, Giuseppe De Nicolao
Pageof 7